Share Price and Basic Stock Data
Last Updated: December 4, 2025, 12:48 am
| PEG Ratio | 4.69 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CRISIL Ltd operates in the services sector, specifically within the “Others” category. The company’s stock price stood at ₹4,452, with a market capitalization of ₹32,550 Cr. CRISIL has reported consistent revenue growth, with sales increasing from ₹2,769 Cr in December 2022 to ₹3,140 Cr in December 2023, and further rising to ₹3,260 Cr in December 2024. The trailing twelve months (TTM) revenue reached ₹3,381 Cr, indicating a robust trajectory. Quarterly sales figures also reflect this growth, with ₹771 Cr reported in June 2023 and ₹736 Cr in September 2023, culminating in a strong December 2023 figure of ₹918 Cr. This upward trend in revenue highlights CRISIL’s effective business strategies and market positioning. The company’s ability to maintain a significant sales volume, alongside a diverse portfolio, positions it favorably within its industry.
Profitability and Efficiency Metrics
CRISIL’s profitability metrics demonstrate strong operational performance. The operating profit margin (OPM) stood at 28% as of the latest reporting, reflecting a consistent ability to manage costs effectively. The net profit for the year ending December 2023 was ₹658 Cr, which rose to ₹684 Cr in December 2024, showcasing a commitment to enhancing profitability. The return on equity (ROE) was reported at 27.8%, while the return on capital employed (ROCE) was an impressive 35.6%, indicating efficient utilization of equity and capital. The interest coverage ratio (ICR) was exceptionally high at 248.25x, suggesting CRISIL’s robust ability to meet interest obligations. However, the cash conversion cycle of 62 days indicates some room for improving operational efficiency in managing working capital. These profitability metrics illustrate CRISIL’s solid financial health and operational effectiveness compared to industry standards.
Balance Sheet Strength and Financial Ratios
CRISIL’s balance sheet reflects considerable financial strength, with total reserves reported at ₹2,809 Cr and borrowings at ₹298 Cr, highlighting a low leverage ratio. The company’s total assets reached ₹4,231 Cr, supported by a substantial increase in fixed assets from ₹619 Cr in December 2022 to ₹976 Cr in December 2024. The current ratio stood at 1.96, indicating adequate liquidity to meet short-term obligations. Additionally, the price-to-book value (P/BV) ratio was noted at 19.05x, suggesting a premium valuation in the market compared to its book value of ₹350.86 per share. The dividend payout ratio was maintained at 60% in December 2024, demonstrating a balanced approach to rewarding shareholders while retaining sufficient earnings for growth. Overall, CRISIL’s financial ratios and balance sheet metrics underline its stability and capacity for sustained growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CRISIL indicates a strong foundation of investor confidence, with promoters holding 66.64% of the company. Institutional investors, including Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs), accounted for 7.81% and 12.17%, respectively. The public shareholding stood at 13.37%, reflecting broad market participation. The number of shareholders increased significantly to 74,565 by June 2025, up from 54,551 in December 2022, showcasing growing interest and confidence in the company’s direction. This stable shareholding structure, with significant promoter backing and increasing public participation, bodes well for CRISIL’s governance and strategic decisions. However, the relatively high promoter holding could also raise concerns regarding liquidity and market responsiveness to minority shareholder interests.
Outlook, Risks, and Final Insight
Looking ahead, CRISIL is well-positioned for continued growth, driven by its strong revenue trajectory and profitability metrics. However, risks such as potential market volatility and economic downturns could impact future performance. The company’s high P/BV ratio may suggest overvaluation, which could deter some investors if market conditions shift. Additionally, the relatively high cash conversion cycle indicates a need for improved management of receivables and payables. Despite these challenges, CRISIL’s robust financial foundation and operational efficiency offer a solid base for navigating potential headwinds. Overall, the company’s strategic initiatives and strong market position suggest a favorable outlook, contingent upon maintaining operational excellence and adapting to market dynamics.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CRISIL Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IMEC Services Ltd | 37.4 Cr. | 197 | 448/44.1 | 1.52 | 138 | 0.00 % | 177 % | 177 % | 10.0 |
| Focus Business Solution Ltd | 103 Cr. | 141 | 142/50.6 | 87.0 | 11.1 | 0.04 % | 15.5 % | 12.4 % | 10.0 |
| EKI Energy Services Ltd | 285 Cr. | 103 | 366/82.4 | 37.0 | 154 | 1.94 % | 3.93 % | 3.46 % | 10.0 |
| CMS Info Systems Ltd | 5,854 Cr. | 356 | 557/340 | 18.2 | 135 | 1.83 % | 21.8 % | 15.7 % | 10.0 |
| Ashram Online.Com Ltd | 5.65 Cr. | 4.71 | 6.59/4.11 | 10.5 | 0.00 % | 0.32 % | 0.57 % | 10.0 | |
| Industry Average | 11,490.53 Cr | 569.40 | 36.99 | 147.57 | 0.60% | 22.28% | 20.60% | 8.65 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 669 | 683 | 822 | 715 | 771 | 736 | 918 | 738 | 797 | 812 | 913 | 813 | 843 |
| Expenses | 499 | 531 | 606 | 511 | 567 | 544 | 649 | 546 | 591 | 588 | 626 | 581 | 604 |
| Operating Profit | 169 | 151 | 216 | 203 | 204 | 192 | 269 | 192 | 207 | 224 | 287 | 232 | 239 |
| OPM % | 25% | 22% | 26% | 28% | 26% | 26% | 29% | 26% | 26% | 28% | 31% | 29% | 28% |
| Other Income | 35 | 65 | 18 | 17 | 18 | 36 | 36 | 21 | 18 | 21 | 30 | 31 | 24 |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 6 | 6 |
| Depreciation | 26 | 26 | 26 | 26 | 26 | 26 | 25 | 17 | 16 | 16 | 21 | 30 | 32 |
| Profit before tax | 177 | 189 | 207 | 194 | 195 | 200 | 279 | 195 | 208 | 229 | 294 | 227 | 225 |
| Tax % | 23% | 22% | 24% | 25% | 23% | 24% | 25% | 30% | 28% | 25% | 24% | 30% | 24% |
| Net Profit | 137 | 148 | 158 | 146 | 151 | 152 | 210 | 138 | 150 | 172 | 225 | 160 | 172 |
| EPS in Rs | 18.75 | 20.24 | 21.63 | 19.94 | 20.60 | 20.79 | 28.74 | 18.84 | 20.53 | 23.46 | 30.72 | 21.86 | 23.46 |
Last Updated: August 1, 2025, 10:30 pm
Below is a detailed analysis of the quarterly data for CRISIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 843.00 Cr.. The value appears strong and on an upward trend. It has increased from 813.00 Cr. (Mar 2025) to 843.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Jun 2025, the value is 604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 581.00 Cr. (Mar 2025) to 604.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 239.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 239.00 Cr., marking an increase of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Mar 2025) to 28.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 7.00 Cr..
- For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 225.00 Cr.. The value appears to be declining and may need further review. It has decreased from 227.00 Cr. (Mar 2025) to 225.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 24.00%, marking a decrease of 6.00%.
- For Net Profit, as of Jun 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Mar 2025) to 172.00 Cr., marking an increase of 12.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.46. The value appears strong and on an upward trend. It has increased from 21.86 (Mar 2025) to 23.46, marking an increase of 1.60.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:58 pm
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,111 | 1,253 | 1,380 | 1,548 | 1,658 | 1,748 | 1,732 | 1,982 | 2,301 | 2,769 | 3,140 | 3,260 | 3,381 |
| Expenses | 750 | 865 | 980 | 1,104 | 1,203 | 1,277 | 1,276 | 1,471 | 1,690 | 2,039 | 2,258 | 2,349 | 2,399 |
| Operating Profit | 361 | 389 | 400 | 443 | 455 | 471 | 456 | 511 | 611 | 730 | 882 | 911 | 982 |
| OPM % | 32% | 31% | 29% | 29% | 27% | 27% | 26% | 26% | 27% | 26% | 28% | 28% | 29% |
| Other Income | 103 | 24 | 43 | 50 | 25 | 73 | 73 | 83 | 123 | 122 | 94 | 90 | 106 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 14 | 9 | 6 | 4 | 4 | 14 |
| Depreciation | 38 | 36 | 37 | 55 | 47 | 43 | 37 | 121 | 106 | 103 | 104 | 70 | 98 |
| Profit before tax | 425 | 376 | 406 | 438 | 434 | 500 | 492 | 458 | 618 | 742 | 868 | 926 | 975 |
| Tax % | 30% | 29% | 30% | 33% | 30% | 27% | 30% | 23% | 25% | 24% | 24% | 26% | |
| Net Profit | 298 | 268 | 285 | 294 | 304 | 363 | 344 | 355 | 466 | 564 | 658 | 684 | 728 |
| EPS in Rs | 42.16 | 37.62 | 40.04 | 41.26 | 42.46 | 50.35 | 47.57 | 48.87 | 63.92 | 77.25 | 90.06 | 93.54 | 99.50 |
| Dividend Payout % | 45% | 53% | 57% | 65% | 66% | 60% | 67% | 68% | 72% | 62% | 60% | 60% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 16% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 23% |
| 3 Years: | 15% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 30% |
| 3 Years: | 31% |
| Last Year: | 28% |
Last Updated: September 5, 2025, 2:20 am
Balance Sheet
Last Updated: July 25, 2025, 3:23 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 667 | 841 | 849 | 978 | 1,041 | 1,129 | 1,165 | 1,305 | 1,571 | 1,785 | 2,182 | 2,558 | 2,809 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 0 | 132 | 83 | 47 | 250 | 298 |
| Other Liabilities | 470 | 416 | 475 | 400 | 446 | 495 | 514 | 895 | 793 | 956 | 1,061 | 1,127 | 1,116 |
| Total Liabilities | 1,145 | 1,265 | 1,331 | 1,385 | 1,495 | 1,634 | 1,689 | 2,207 | 2,504 | 2,831 | 3,297 | 3,942 | 4,231 |
| Fixed Assets | 449 | 432 | 413 | 309 | 293 | 350 | 349 | 763 | 661 | 619 | 635 | 976 | 1,085 |
| CWIP | 0 | 0 | 3 | 4 | 13 | 7 | 12 | 14 | 5 | 14 | 31 | 55 | 0 |
| Investments | 244 | 375 | 383 | 465 | 525 | 477 | 453 | 476 | 645 | 683 | 1,056 | 1,454 | 1,390 |
| Other Assets | 451 | 458 | 532 | 607 | 663 | 800 | 875 | 955 | 1,193 | 1,515 | 1,576 | 1,457 | 1,755 |
| Total Assets | 1,145 | 1,265 | 1,331 | 1,385 | 1,495 | 1,634 | 1,689 | 2,207 | 2,504 | 2,831 | 3,297 | 3,942 | 4,231 |
Below is a detailed analysis of the balance sheet data for CRISIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
- For Reserves, as of Jun 2025, the value is 2,809.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,558.00 Cr. (Dec 2024) to 2,809.00 Cr., marking an increase of 251.00 Cr..
- For Borrowings, as of Jun 2025, the value is 298.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 250.00 Cr. (Dec 2024) to 298.00 Cr., marking an increase of 48.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 1,116.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,127.00 Cr. (Dec 2024) to 1,116.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 4,231.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,942.00 Cr. (Dec 2024) to 4,231.00 Cr., marking an increase of 289.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 1,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 976.00 Cr. (Dec 2024) to 1,085.00 Cr., marking an increase of 109.00 Cr..
- For CWIP, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 55.00 Cr..
- For Investments, as of Jun 2025, the value is 1,390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,454.00 Cr. (Dec 2024) to 1,390.00 Cr., marking a decrease of 64.00 Cr..
- For Other Assets, as of Jun 2025, the value is 1,755.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,457.00 Cr. (Dec 2024) to 1,755.00 Cr., marking an increase of 298.00 Cr..
- For Total Assets, as of Jun 2025, the value is 4,231.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,942.00 Cr. (Dec 2024) to 4,231.00 Cr., marking an increase of 289.00 Cr..
Notably, the Reserves (2,809.00 Cr.) exceed the Borrowings (298.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 361.00 | 389.00 | 400.00 | 443.00 | 455.00 | 468.00 | 453.00 | 511.00 | 479.00 | 647.00 | 835.00 | 661.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39 | 41 | 52 | 49 | 57 | 59 | 42 | 57 | 86 | 100 | 78 | 62 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 39 | 41 | 52 | 49 | 57 | 59 | 42 | 57 | 86 | 100 | 78 | 62 |
| Working Capital Days | -86 | -46 | -39 | -7 | 2 | -9 | -27 | -35 | -18 | 0 | -7 | -36 |
| ROCE % | 60% | 48% | 45% | 45% | 41% | 45% | 42% | 37% | 38% | 41% | 41% | 36% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Magnum Midcap Fund | 1,395,281 | 3.39 | 607.83 | 1,395,281 | 2025-04-22 17:25:38 | 0% |
| Kotak Equity Opportunities Fund - Regular Plan | 555,000 | 1.12 | 241.78 | 555,000 | 2025-04-22 17:25:38 | 0% |
| Quant Active Fund | 402,300 | 1.79 | 175.26 | 402,300 | 2025-04-22 17:25:38 | 0% |
| HSBC Midcap Fund | 375,147 | 1.58 | 163.43 | 375,147 | 2025-04-22 17:25:38 | 0% |
| Quant Mid Cap Fund | 263,137 | 1.66 | 114.63 | 263,137 | 2025-04-22 17:25:38 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 214,418 | 2.56 | 93.41 | 214,418 | 2025-04-22 17:25:38 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 214,418 | 2.56 | 93.41 | 214,418 | 2025-04-22 17:25:38 | 0% |
| PGIM India Midcap Opportunities Fund | 173,973 | 0.75 | 75.79 | 173,973 | 2025-04-22 17:25:38 | 0% |
| UTI MNC Fund | 136,975 | 2.1 | 59.67 | 136,975 | 2025-04-22 17:25:38 | 0% |
| Kotak ELSS Tax Saver Fund | 115,000 | 0.89 | 50.1 | 115,000 | 2025-04-22 17:25:38 | 0% |
Key Financial Ratios
| Month | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 93.55 | 90.08 | 77.31 | 64.03 | 48.93 |
| Diluted EPS (Rs.) | 93.55 | 90.07 | 77.31 | 63.96 | 48.93 |
| Cash EPS (Rs.) | 103.15 | 104.27 | 91.34 | 78.43 | 65.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 350.86 | 299.44 | 245.14 | 216.21 | 180.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 350.86 | 299.44 | 245.14 | 216.21 | 180.69 |
| Revenue From Operations / Share (Rs.) | 445.93 | 429.48 | 378.76 | 315.60 | 272.98 |
| PBDIT / Share (Rs.) | 136.86 | 133.40 | 116.57 | 94.31 | 81.79 |
| PBIT / Share (Rs.) | 127.29 | 119.20 | 102.44 | 79.77 | 65.11 |
| PBT / Share (Rs.) | 126.74 | 118.70 | 101.56 | 84.83 | 63.13 |
| Net Profit / Share (Rs.) | 93.58 | 90.07 | 77.21 | 63.90 | 48.86 |
| NP After MI And SOA / Share (Rs.) | 93.58 | 90.07 | 77.21 | 63.90 | 48.86 |
| PBDIT Margin (%) | 30.69 | 31.06 | 30.77 | 29.88 | 29.96 |
| PBIT Margin (%) | 28.54 | 27.75 | 27.04 | 25.27 | 23.85 |
| PBT Margin (%) | 28.42 | 27.63 | 26.81 | 26.88 | 23.12 |
| Net Profit Margin (%) | 20.98 | 20.97 | 20.38 | 20.24 | 17.89 |
| NP After MI And SOA Margin (%) | 20.98 | 20.97 | 20.38 | 20.24 | 17.89 |
| Return on Networth / Equity (%) | 26.67 | 30.08 | 31.49 | 29.55 | 27.04 |
| Return on Capital Employeed (%) | 32.64 | 37.75 | 39.67 | 34.16 | 31.14 |
| Return On Assets (%) | 17.35 | 19.86 | 19.93 | 18.60 | 16.07 |
| Asset Turnover Ratio (%) | 0.89 | 1.02 | 1.04 | 0.65 | 0.58 |
| Current Ratio (X) | 1.96 | 2.08 | 1.87 | 1.79 | 1.57 |
| Quick Ratio (X) | 1.96 | 2.08 | 1.87 | 1.79 | 1.57 |
| Dividend Payout Ratio (NP) (%) | 61.99 | 54.39 | 60.79 | 59.35 | 65.41 |
| Dividend Payout Ratio (CP) (%) | 56.24 | 46.98 | 51.39 | 48.35 | 48.76 |
| Earning Retention Ratio (%) | 38.01 | 45.61 | 39.21 | 40.65 | 34.59 |
| Cash Earning Retention Ratio (%) | 43.76 | 53.02 | 48.61 | 51.65 | 51.24 |
| Interest Coverage Ratio (X) | 248.25 | 266.43 | 133.14 | 76.99 | 41.26 |
| Interest Coverage Ratio (Post Tax) (X) | 170.74 | 180.90 | 89.19 | 48.03 | 25.65 |
| Enterprise Value (Cr.) | 48557.78 | 31351.85 | 22093.95 | 20741.31 | 13681.21 |
| EV / Net Operating Revenue (X) | 14.90 | 9.99 | 7.98 | 9.02 | 6.90 |
| EV / EBITDA (X) | 48.54 | 32.15 | 25.93 | 30.17 | 23.04 |
| MarketCap / Net Operating Revenue (X) | 14.99 | 10.10 | 8.10 | 9.14 | 7.04 |
| Retention Ratios (%) | 38.00 | 45.60 | 39.20 | 40.64 | 34.58 |
| Price / BV (X) | 19.05 | 14.49 | 12.51 | 13.35 | 10.64 |
| Price / Net Operating Revenue (X) | 14.99 | 10.10 | 8.10 | 9.14 | 7.04 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for CRISIL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Dec 24, the value is 93.55. This value is within the healthy range. It has increased from 90.08 (Dec 23) to 93.55, marking an increase of 3.47.
- For Diluted EPS (Rs.), as of Dec 24, the value is 93.55. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.55, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Dec 24, the value is 103.15. This value is within the healthy range. It has decreased from 104.27 (Dec 23) to 103.15, marking a decrease of 1.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 350.86. It has increased from 299.44 (Dec 23) to 350.86, marking an increase of 51.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 350.86. It has increased from 299.44 (Dec 23) to 350.86, marking an increase of 51.42.
- For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 445.93. It has increased from 429.48 (Dec 23) to 445.93, marking an increase of 16.45.
- For PBDIT / Share (Rs.), as of Dec 24, the value is 136.86. This value is within the healthy range. It has increased from 133.40 (Dec 23) to 136.86, marking an increase of 3.46.
- For PBIT / Share (Rs.), as of Dec 24, the value is 127.29. This value is within the healthy range. It has increased from 119.20 (Dec 23) to 127.29, marking an increase of 8.09.
- For PBT / Share (Rs.), as of Dec 24, the value is 126.74. This value is within the healthy range. It has increased from 118.70 (Dec 23) to 126.74, marking an increase of 8.04.
- For Net Profit / Share (Rs.), as of Dec 24, the value is 93.58. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.58, marking an increase of 3.51.
- For NP After MI And SOA / Share (Rs.), as of Dec 24, the value is 93.58. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.58, marking an increase of 3.51.
- For PBDIT Margin (%), as of Dec 24, the value is 30.69. This value is within the healthy range. It has decreased from 31.06 (Dec 23) to 30.69, marking a decrease of 0.37.
- For PBIT Margin (%), as of Dec 24, the value is 28.54. This value exceeds the healthy maximum of 20. It has increased from 27.75 (Dec 23) to 28.54, marking an increase of 0.79.
- For PBT Margin (%), as of Dec 24, the value is 28.42. This value is within the healthy range. It has increased from 27.63 (Dec 23) to 28.42, marking an increase of 0.79.
- For Net Profit Margin (%), as of Dec 24, the value is 20.98. This value exceeds the healthy maximum of 10. It has increased from 20.97 (Dec 23) to 20.98, marking an increase of 0.01.
- For NP After MI And SOA Margin (%), as of Dec 24, the value is 20.98. This value exceeds the healthy maximum of 20. It has increased from 20.97 (Dec 23) to 20.98, marking an increase of 0.01.
- For Return on Networth / Equity (%), as of Dec 24, the value is 26.67. This value is within the healthy range. It has decreased from 30.08 (Dec 23) to 26.67, marking a decrease of 3.41.
- For Return on Capital Employeed (%), as of Dec 24, the value is 32.64. This value is within the healthy range. It has decreased from 37.75 (Dec 23) to 32.64, marking a decrease of 5.11.
- For Return On Assets (%), as of Dec 24, the value is 17.35. This value is within the healthy range. It has decreased from 19.86 (Dec 23) to 17.35, marking a decrease of 2.51.
- For Asset Turnover Ratio (%), as of Dec 24, the value is 0.89. It has decreased from 1.02 (Dec 23) to 0.89, marking a decrease of 0.13.
- For Current Ratio (X), as of Dec 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.08 (Dec 23) to 1.96, marking a decrease of 0.12.
- For Quick Ratio (X), as of Dec 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.08 (Dec 23) to 1.96, marking a decrease of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Dec 24, the value is 61.99. This value exceeds the healthy maximum of 50. It has increased from 54.39 (Dec 23) to 61.99, marking an increase of 7.60.
- For Dividend Payout Ratio (CP) (%), as of Dec 24, the value is 56.24. This value exceeds the healthy maximum of 50. It has increased from 46.98 (Dec 23) to 56.24, marking an increase of 9.26.
- For Earning Retention Ratio (%), as of Dec 24, the value is 38.01. This value is below the healthy minimum of 40. It has decreased from 45.61 (Dec 23) to 38.01, marking a decrease of 7.60.
- For Cash Earning Retention Ratio (%), as of Dec 24, the value is 43.76. This value is within the healthy range. It has decreased from 53.02 (Dec 23) to 43.76, marking a decrease of 9.26.
- For Interest Coverage Ratio (X), as of Dec 24, the value is 248.25. This value is within the healthy range. It has decreased from 266.43 (Dec 23) to 248.25, marking a decrease of 18.18.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 170.74. This value is within the healthy range. It has decreased from 180.90 (Dec 23) to 170.74, marking a decrease of 10.16.
- For Enterprise Value (Cr.), as of Dec 24, the value is 48,557.78. It has increased from 31,351.85 (Dec 23) to 48,557.78, marking an increase of 17,205.93.
- For EV / Net Operating Revenue (X), as of Dec 24, the value is 14.90. This value exceeds the healthy maximum of 3. It has increased from 9.99 (Dec 23) to 14.90, marking an increase of 4.91.
- For EV / EBITDA (X), as of Dec 24, the value is 48.54. This value exceeds the healthy maximum of 15. It has increased from 32.15 (Dec 23) to 48.54, marking an increase of 16.39.
- For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 14.99. This value exceeds the healthy maximum of 3. It has increased from 10.10 (Dec 23) to 14.99, marking an increase of 4.89.
- For Retention Ratios (%), as of Dec 24, the value is 38.00. This value is within the healthy range. It has decreased from 45.60 (Dec 23) to 38.00, marking a decrease of 7.60.
- For Price / BV (X), as of Dec 24, the value is 19.05. This value exceeds the healthy maximum of 3. It has increased from 14.49 (Dec 23) to 19.05, marking an increase of 4.56.
- For Price / Net Operating Revenue (X), as of Dec 24, the value is 14.99. This value exceeds the healthy maximum of 3. It has increased from 10.10 (Dec 23) to 14.99, marking an increase of 4.89.
- For EarningsYield, as of Dec 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Dec 23) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CRISIL Ltd:
- Net Profit Margin: 20.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.64% (Industry Average ROCE: 22.28%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 26.67% (Industry Average ROE: 20.6%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 170.74
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.4 (Industry average Stock P/E: 33.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.98%
Fundamental Analysis of CRISIL Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Services - Others | CRISIL House, Central Avenue, Mumbai Maharashtra 400076 | investors@crisil.com http://www.crisil.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yann Le Pallec | Chairman |
| Mr. Amish Mehta | Managing Director & CEO |
| Mr. Girish Paranjpe | Independent Director |
| Ms. Shyamala Gopinath | Independent Director |
| Mr. Amar Raj Bindra | Independent Director |
| Mr. Nishi Vasudeva | Independent Director |
| Mr. Saugata Saha | Director |
| Mr. Girish Ganesan | Director |
Crisil Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹4,418.25 |
| Previous Day | ₹4,449.70 |
FAQ
What is the intrinsic value of CRISIL Ltd?
CRISIL Ltd's intrinsic value (as of 04 December 2025) is 3736.89 which is 16.06% lower the current market price of 4,452.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 32,550 Cr. market cap, FY2025-2026 high/low of 6,955/3,894, reserves of ₹2,809 Cr, and liabilities of 4,231 Cr.
What is the Market Cap of CRISIL Ltd?
The Market Cap of CRISIL Ltd is 32,550 Cr..
What is the current Stock Price of CRISIL Ltd as on 04 December 2025?
The current stock price of CRISIL Ltd as on 04 December 2025 is 4,452.
What is the High / Low of CRISIL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CRISIL Ltd stocks is 6,955/3,894.
What is the Stock P/E of CRISIL Ltd?
The Stock P/E of CRISIL Ltd is 43.4.
What is the Book Value of CRISIL Ltd?
The Book Value of CRISIL Ltd is 385.
What is the Dividend Yield of CRISIL Ltd?
The Dividend Yield of CRISIL Ltd is 0.56 %.
What is the ROCE of CRISIL Ltd?
The ROCE of CRISIL Ltd is 35.6 %.
What is the ROE of CRISIL Ltd?
The ROE of CRISIL Ltd is 27.8 %.
What is the Face Value of CRISIL Ltd?
The Face Value of CRISIL Ltd is 1.00.